Thymosin Alpha-1
A 28-amino-acid thymic peptide that activates dendritic cells and drives T-cell differentiation, acting as a master modulator of adaptive immunity and serving as a benchmark for immune system integrity.
A 28-amino-acid thymic peptide that activates dendritic cells and drives T-cell differentiation, acting as a master modulator of adaptive immunity and serving as a benchmark for immune system integrity.
Thymosin Alpha-1 promotes T-cell maturation and differentiation from thymic precursors, upregulates MHC class II expression on antigen-presenting cells, and modulates TLR9 signaling to balance innate and adaptive immunity. It enhances NK cell and cytotoxic T-lymphocyte activity, making it relevant to both immune deficiency and immune dysregulation contexts. Decades of clinical use support its safety and immunomodulatory breadth.
- [1]Goldstein AL, Goldstein AL. (2009). From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opinion on Biological Therapy, 9(5):593-608.
- [2]Costantini C, et al. (2008). Thymosin alpha1 activates complement receptor 3-mediated phagocytosis in human monocyte-derived dendritic cells. Journal of Leukocyte Biology, 83(6):1420-1430.
- [3]Matteucci C, et al. (2000). Thymosin alpha 1 and interleukin 2 effects on the immune system. Journal of Biological Regulators and Homeostatic Agents, 14(4):272-278.
Educational Content Only. This information is provided for research awareness and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare professional before making any health decisions.